What's the Next Big Thing in the Peptide Therapeutics Market? Eli Lilly and Company, AstraZeneca Plc, Merck & Co., Inc., Ipsen S.A, Novo Nordisk A/S
Future Market Insights' latest market study on peptide therapeutics reports that peptide therapeutics is potentially a large market and is expanding extensively with a CAGR of 10.3% over 2015–2025. Expansion of indications for therapeutic peptides is a leading factor driving the growth in market value, says FMI report. Peptides are being used as therapeutic agents from 1950s. However, initially peptides were either hormone or analog closely related to hormone. Hence, primary indications of early peptides were limited to treatment of...
View full press release